3.0.0 4244 2022-11-01T13:50:07Z 2022-11-01T13:50:07Z House HR 2019-09-09 116 [Congressional Record Volume 165, Number 143 (Monday, September 9, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. KELLY of Pennsylvania:H.R. 4244.Congress has the power to enact this legislation pursuantto the following:The Congress enacts this bill pursuant to Article I,Section 8, Clause 3--Commerce Clause--of the United StatesConstitution.[Page H7559]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-09-10T16:08:48Z Referred to 2019-09-09T18:01:25Z 2019-09-10 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-09-09 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-09-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-09-09 Introduced in House IntroReferral 1000 9 Library of Congress K000376 Rep. Kelly, Mike [R-PA-16] Mike Kelly R PA 16 N P000605 Rep. Perry, Scott [R-PA-10] Scott Perry R PA 10 2019-12-23 False T000467 Rep. Thompson, Glenn [R-PA-15] Glenn Thompson R PA 15 2019-12-23 False F000466 Rep. Fitzpatrick, Brian K. [R-PA-1] Brian Fitzpatrick R PA K. 1 2019-12-23 False K000395 Rep. Keller, Fred [R-PA-12] Fred Keller R PA 12 2020-02-04 False Health Competition and antitrust Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Licensing and registrations Manufacturing Prescription drugs Health 00 2019-09-09 Introduced in House 2021-09-14T13:53:47Z Market Access for Generic Insulin Competition or the MAGIC Act

This bill provides a pathway for the Food and Drug Administration to approve chemically synthesized insulin or an analogue of chemically synthesized insulin as a generic drug under the abbreviated new drug application process.

]]> MAGIC Act Display Title MAGIC Act Override Display Title MAGIC Act Official Title as Introduced To provide for a pathway for chemically synthesized insulin to be approved under an abbreviated new drug application submitted under the Federal Food, Drug, and Cosmetic Act, and for other purposes. Introduced in House IH Short Title(s) as Introduced MAGIC Act Introduced in House IH Short Title(s) as Introduced Market Access for Generic Insulin Competition Introduced in House IH Introduced in House 2019-09-09T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr4244ih/xml/BILLS-116hr4244ih.xml 2019-09-10 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.